Hyperbaric Oxygen Therapy

Hyperbaric Oxygen Therapy delivers oxygen at 2.0-2.4 ATA and shows the strongest evidence for medically indicated conditions such as decompression illness, carbon monoxide poisoning, and certain hard-to-heal wounds, while off-label benefits appear modest for chronic post-stroke recovery, fibromyalgia, and age-related cognitive complaints; the evidence does not support routine use for acute ischemic stroke or long-COVID symptom relief. Trials like the 2025 HOT-LoCO study found no advantage over sham for long-COVID outcomes, highlighting the need for caution in that indication (Kjellberg 2025). Meta-analyses of wound-care trials report improved healing when hyperbaric oxygen is added to negative-pressure therapy, suggesting a role for selected chronic ulcers (Yang 2024). Neuro-rehabilitation data remain mixed, with small studies hinting at cognitive gains but larger, higher-quality trials still required to confirm those signals.

✅ Best for: Patients with UHMS-accepted indications first: decompression sickness, carbon monoxide poisoning, arterial gas embolism, selected diabetic foot ulcers, delayed radiation injury, refractory osteomyelitis, compromised grafts/flaps, sudden sensorineural hearing loss, intracranial abscess, severe anemia, and other established clinical uses. Off-label, the best fit is older adults with documented cognitive complaints considering a hard-chamber protocol like Hadanny 2020, chronic post-stroke patients per Efrati 2013, fibromyalgia patients per Efrati 2015, selected wound-care patients where Yang 2024 is relevant, and serious experimenters who can afford a full protocol without displacing higher-confidence health basics.

❌ Avoid if: You have untreated pneumothorax, relevant bleomycin exposure without specialist clearance, active doxorubicin/cisplatin/disulfiram exposure, severe COPD with bullae, uncontrolled diabetes, current fever or upper-respiratory infection, recent ear/sinus surgery without ENT clearance, severe claustrophobia, or elective pregnancy use. Avoid wellness clinics that cannot clearly explain fire prevention, screening, oxygen protocols, emergency procedures, and pressure tier. Avoid soft-chamber 1.3 ATA if you expect the hard-chamber outcomes reported in cognitive-aging, fibromyalgia, or chronic post-stroke studies. Avoid long-COVID packages marketed as settled science after Kjellberg 2025.